Literature DB >> 25421417

[Nutrition and dietary supplements in psychiatric diseases].

H Himmerich1, F Erbguth.   

Abstract

Nutrition and specific nutritional supplements can have prophylactic or therapeutic properties with respect to certain psychiatric disorders. A traditional Mediterranean diet, for example, seems to have prophylactic benefits against depression and dementia, whereas overeating and obesity increase the risk for both.Although evidence for nutritional supplements in the treatment of psychiatric disorders is not sufficient for general recommendations, data from observational studies and randomized controlled trials (RCT) seem to point to their use for specific indications. Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.Psychiatric disorders, in turn, may lead to deficiency of mineral nutrients and vitamins. For instance, vitamin B1 (thiamine) deficiency is common in alcohol-dependent patients and should therefore be considered during withdrawal treatment. Although vitamin malnutrition is uncommon in developed countries, vitamin deficiency syndromes, such as pernicious anemia or Wernicke's encephalopathy are still relevant differential diagnoses.Some psychopharmacological drugs may additionally change the nutritional habits of the patients in an unfavorable way leading to weight gain and obesity and the risk for further psychiatric problems.

Entities:  

Mesh:

Year:  2014        PMID: 25421417     DOI: 10.1007/s00115-014-4163-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  44 in total

1.  Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up.

Authors:  Cédric Annweiler; Yves Rolland; Anne M Schott; Hubert Blain; Bruno Vellas; François R Herrmann; Olivier Beauchet
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-13       Impact factor: 6.053

Review 2.  [Antihistaminergic antipsychotics cause weight gain].

Authors:  T Veselinović; H Himmerich
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

3.  Investigating the response to intravenous iron in restless legs syndrome: an observational study.

Authors:  Magdolna Hornyak; Hanna Scholz; Andrea Kiemen; Jan Kassubek
Journal:  Sleep Med       Date:  2012-04-12       Impact factor: 3.492

Review 4.  Cytokines as biomarkers in depressive disorder: current standing and prospects.

Authors:  Nicole Lichtblau; Frank M Schmidt; Robert Schumann; Kenneth C Kirkby; Hubertus Himmerich
Journal:  Int Rev Psychiatry       Date:  2013-10

Review 5.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.

Authors:  Floriana S Luppino; Leonore M de Wit; Paul F Bouvy; Theo Stijnen; Pim Cuijpers; Brenda W J H Penninx; Frans G Zitman
Journal:  Arch Gen Psychiatry       Date:  2010-03

6.  Iron deficiency in children with attention-deficit/hyperactivity disorder.

Authors:  Eric Konofal; Michel Lecendreux; Isabelle Arnulf; Marie-Christine Mouren
Journal:  Arch Pediatr Adolesc Med       Date:  2004-12

7.  Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women.

Authors:  J C Dumville; J N V Miles; J Porthouse; S Cockayne; L Saxon; C King
Journal:  J Nutr Health Aging       Date:  2006 Mar-Apr       Impact factor: 4.075

Review 8.  [Obesity and depression: an overview on the complex interactions of two diseases].

Authors:  J Thormann; T Chittka; J Minkwitz; M Kluge; H Himmerich
Journal:  Fortschr Neurol Psychiatr       Date:  2013-03-20       Impact factor: 0.752

9.  Effects of iron supplementation on attention deficit hyperactivity disorder in children.

Authors:  Eric Konofal; Michel Lecendreux; Juliette Deron; Martine Marchand; Samuele Cortese; Mohammed Zaïm; Marie Christine Mouren; Isabelle Arnulf
Journal:  Pediatr Neurol       Date:  2008-01       Impact factor: 3.372

10.  Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].

Authors:  Shahin Akhondzadeh; Mohammad-Reza Mohammadi; Mojgan Khademi
Journal:  BMC Psychiatry       Date:  2004-04-08       Impact factor: 3.630

View more
  1 in total

1.  Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial.

Authors:  Ali Ghaleiha; Hassan Davari; Leila Jahangard; Mohammad Haghighi; Mohammad Ahmadpanah; Mohammad Ali Seifrabie; Hafez Bajoghli; Edith Holsboer-Trachsler; Serge Brand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-03-16       Impact factor: 5.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.